EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

Eduardo Magalhães Rego, Rafael Henriques Jácomo
  • Eduardo Magalhães Rego
    National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology/Hematology, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo,, Italy | emrego@hcrp.fmrp.usp.br
  • Rafael Henriques Jácomo
    Department of Internal Medicine, Medical School, University of Brasília, Brazil,

Abstract

Distinct epidemiological characteristics have been described in Acute Promielocytic Leukemia (APL). Populations from Latin America have a higher incidence of APL and in some geographic areas a distinct distribution of the PML-RARA isoforms is present. Here, we review the main differences in APL epidemilogy in Latin America as well as treatment outcomes.

Keywords

Leukemia, Acute Promylocytic Leukemia, Latin America, Epidemiology

Full Text:

PDF
HTML
Submitted: 2014-06-12 16:03:29
Published: 2011-10-24 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
365

Views:
PDF
134
HTML
1083

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185